Geovax announces closing of $10.3 million bought deal offering

Atlanta, ga, feb. 11, 2021 (globe newswire) -- via newmediawire -- geovax labs, inc. (nasdaqcm: govx) (“geovax” or the “company”), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, today announced the closing of its bought deal offering of 1,644,000 shares of its common stock, which included 204,000 shares sold pursuant to the full exercise of the underwriter's option to purchase additional shares, at a price to the public of $6.25, less underwriting discounts and commissions.  the gross proceeds from the offering were approximately $10.3 million, before deducting underwriting discounts and commissions and estimated offering expenses.
GOVX Ratings Summary
GOVX Quant Ranking